Intermediate Uveitis in an HLA-B27-Positive Patient Treated with Upadacitinib

Klin Monbl Augenheilkd. 2022 Apr;239(4):572-574. doi: 10.1055/a-1766-6739. Epub 2022 Apr 26.

Authors

Julie Schneider¹, Ann Schalenbourg¹, Jean Dudler², Yan Guex-Crosier¹

Affiliations

¹ Ophthalmology, Hôpital ophtalmique Jules-Gonin, University of Lausanne, Lausanne, Switzerland.
² Department of Rheumatology, HFR, Fribourg, Switzerland.

PMID: 35472808
DOI: 10.1055/a-1766-6739

No abstract available

Publication types

Case Reports

MeSH terms

HLA-B27 Antigen*
Heterocyclic Compounds, 3-Ring
Humans
Uveitis, Intermediate*

Substances

HLA-B27 Antigen
Heterocyclic Compounds, 3-Ring
upadacitinib